Elevated levels of kynurenic acid during gestation produce neurochemical, morphological, and cognitive deficits in adulthood: implications for schizophrenia.
about
Kynurenine 3-Monooxygenase: An Influential Mediator of NeuropathologyThe NMDA Receptor and Schizophrenia: From Pathophysiology to Treatment.Prolonged Subdural Infusion of Kynurenic Acid Is Associated with Dose-Dependent Myelin Damage in the Rat Spinal CordAltered hippocampal plasticity by prenatal kynurenine administration, kynurenine-3-monoxygenase (KMO) deletion or galantamineAstrocytes as secretory cells of the central nervous system: idiosyncrasies of vesicular secretionModeling neurodevelopmental cognitive deficits in tasks with cross-species translational validityPreferential Disruption of Prefrontal GABAergic Function by Nanomolar Concentrations of the α7nACh Negative Modulator Kynurenic Acid.Elevated kynurenine pathway metabolism during neurodevelopment: Implications for brain and behavior.Towards an Immunophenotype of Schizophrenia: Progress, Potential Mechanisms, and Future Directions.Kynurenines and Glutamate: Multiple Links and Therapeutic Implications.Kynurenic Acid in Schizophrenia: A Systematic Review and Meta-analysis.Cross Talk: The Microbiota and Neurodevelopmental Disorders.Tryptophan Metabolism and White Matter Integrity in Schizophrenia.Exposure to intrauterine inflammation alters metabolomic profiles in the amniotic fluid, fetal and neonatal brain in the mouse.Prenatal kynurenine exposure in rats: age-dependent changes in NMDA receptor expression and conditioned fear responding.Maternal protein restriction during gestation and lactation in the rat results in increased brain levels of kynurenine and kynurenic acid in their adult offspring.Prenatal kynurenine treatment in rats causes schizophrenia-like broad monitoring deficits in adulthood.Restraint Stress during Pregnancy Rapidly Raises Kynurenic Acid Levels in Mouse Placenta and Fetal Brain.Oral administration of a specific kynurenic acid synthesis (KAT II) inhibitor attenuates evoked glutamate release in rat prefrontal cortex.
P2860
Q26782867-A26462BB-2DEE-43CE-B18F-D2DB1166A7BDQ33920257-5285A421-9CB9-41EE-BB67-3316F762B152Q35840053-D2202C42-3904-46DB-9A77-45EE78E74207Q36273903-D94AE48F-A845-4A5B-800A-7577FC8AFBB4Q36543708-8E97A9A3-07F9-43F5-8057-FA87F37011DBQ37126507-EFC5F0C4-EED8-4851-AE10-CA0EED480EA9Q38669116-5EBB674D-8849-48B1-BEFC-FF5D40198EB3Q38761405-3EA02C5A-5C66-41B7-BB07-5B0EB8D705CDQ38809444-FCC10C84-2B5D-41F3-99FE-9968642B6757Q38861843-2F97FA82-00CA-4458-B17B-3AF3975F505CQ39130393-DAF09910-AE80-472A-BA9F-745706AEC52EQ41665354-D8CFB384-3E5C-400B-8716-74356EA1E681Q41725053-9E863A73-F2D1-468E-AA55-E286B84AB892Q47168684-31C892CB-645A-4218-98DE-75196F282954Q47401011-C9F8BA95-B39A-45A6-9DFA-EF6FF3D732C7Q47902256-62006557-6AEC-4DF5-91A3-4D9D5A7B019CQ47973666-84CD3667-26A5-4863-98D2-A7A87CC09D1DQ48302638-5490788F-11A4-42DC-8468-64E4B7C2937DQ50331698-EAF0EA94-CA0E-441E-A0C2-938CF6F5C400
P2860
Elevated levels of kynurenic acid during gestation produce neurochemical, morphological, and cognitive deficits in adulthood: implications for schizophrenia.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Elevated levels of kynurenic a ...... mplications for schizophrenia.
@ast
Elevated levels of kynurenic a ...... mplications for schizophrenia.
@en
type
label
Elevated levels of kynurenic a ...... mplications for schizophrenia.
@ast
Elevated levels of kynurenic a ...... mplications for schizophrenia.
@en
prefLabel
Elevated levels of kynurenic a ...... mplications for schizophrenia.
@ast
Elevated levels of kynurenic a ...... mplications for schizophrenia.
@en
P2093
P2860
P1433
P1476
Elevated levels of kynurenic a ...... implications for schizophrenia
@en
P2093
Ana Pocivavsek
Benedetta Leuner
David M Bortz
John P Bruno
Michelle L Pershing
Peter J Fredericks
Robert Schwarcz
Sarah A Vunck
P2860
P356
10.1016/J.NEUROPHARM.2014.10.017
P577
2014-11-01T00:00:00Z